Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

BlueRock Therapeutics: Ontario’s home-grown stem cell contender

New Toronto-based regenerative medicine biotech BlueRock Therapeutics was launched in December with a massive $225m series A financing from Bayer and Versant Ventures. What stem cell-based therapies is the company working on to justify this investor confidence, and what are the benefits of operating in the life sciences hub of one of the world’s most diverse cities?

Go Top